ANTIBIOTICE
84 articole · RSS
Antibiotice Feels The Pinch Of Falling Prices And Russian Crisis
Romanian state-run drug maker Antibiotice Iasi says its exports, weighing 30% in revenue, felt the fallout of declining prices internationally, as well as of the crisis in Russia and Ukraine...
Antibiotice Sales Revenue Flat In First 9 Months, At RON217M
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Friday said its sales revenues were flat on the year at 217.2 million lei (EUR48.8 million) in January-September 2014.
Antibiotice 1H Net Profit Up 6.3% At RON18.3M
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a net profit worth 18.3 million lei (EUR4.09 million) in January-June, up 6.3% from RON17.21 million in the corresponding peri...
Antibiotice Iasi Invests EUR10M In New Ointment And Suppository Facility
Health Ministry-owned drug producer Antibiotice Iasi (ATB.RO) will invest EUR10 million in a new ointment and suppository production facility in 2014-2016, whose products it will sell in Rom...
Antibiotice 1Q Sales Revenue Up 2% On Year To RON60.55M
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Thursday reported a 2% increase in sales revenue to 60.55 million lei (EUR13.6 million) in the first quarter of 2014, from RON59.44 mil...
Antibiotice Plans To Invest EUR40M In New Production Units By 2020
Romanian state-run drug-maker Antibiotice Iasi (ATB.RO wants to build new production facilities to develop its product portfolio and estimates it will invest EUR40 million over the next six...
Antibiotice Iasi Pays Dividends Of RON15.4M, Nearly Half Of 2013 Profit
Romanian state-run drug-maker Antibiotice Iasi (ATB.RO) is paying dividends totaling RON15.4 million, nearly half of the profit it made in 2013, and the Health Ministry, the majority shareho...
Antibiotice, Biofarm or Zentiva: Which Pharma Stock To Invest In?
Zentiva Bucuresti (SCD.RO) is paying the highest dividend of all pharmaceutical producers listed on the Bucharest stock market, while Biofarm (BIO.RO) will not be paying any. Analysts’ favor...
Antibiotice Proposes RON15.4M Dividend For 2013
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) proposes a dividend payment of 15.4 million lei (EUR3.44 million) from the 2013 profits, the company said in a call to its shareholders...